Lidds AB
5LD
Company Profile
Business description
Lidds AB is a Swedish pharmaceutical company developing pharmaceutical products based on medical needs and its proprietary drug delivery technology.
Contact
Virdings alle 32B
Uppsala754 50
SWESector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
1
Stocks News & Analysis
stocks
Alphabet earnings: Continued momentum on cloud and search as capital expenses set to mount
Strong fourth quarter earnings.
stocks
Eli Lilly earnings: Revenue increases reflect global demand for oral obesity therapies
We’ve raised our fair value estimate of Lilly stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,154.90 | 49.70 | -0.54% |
| CAC 40 | 8,238.17 | 23.99 | -0.29% |
| DAX 40 | 24,491.06 | 111.98 | -0.46% |
| Dow JONES (US) | 48,988.68 | 252.31 | -0.51% |
| FTSE 100 | 10,309.22 | 93.12 | -0.90% |
| HKSE | 26,885.24 | 37.92 | 0.14% |
| NASDAQ | 22,629.24 | 625.95 | -2.69% |
| Nikkei 225 | 53,818.04 | 475.32 | -0.88% |
| NZX 50 Index | 13,444.02 | 23.27 | -0.17% |
| S&P 500 | 6,813.02 | 69.70 | -1.01% |
| S&P/ASX 200 | 8,889.20 | 38.60 | -0.43% |
| SSE Composite Index | 4,075.92 | 26.29 | -0.64% |